BrianNussenbaumMD
Otolaryngology (ENT) • Houston, TXHead & Neck Microvascular Surgery, Head & Neck Oncologic Surgery
Executive Director, Elect, American Board of Otolaryngology
Dr. Nussenbaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5615 Kirby Drive
Suite 600
Houston, TX 77005Phone+1 713-850-0399Fax+1 713-850-1104
Education & Training
University of Michigan Health SystemFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2000 - 2002
University of Texas Southwestern Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1996 - 2000
New York University School of MedicineClass of 1994
Certifications & Licensure
TX State Medical License 1995 - 2026
MI State Medical License 2000 - 2025
MO State Medical License 2002 - 2025- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- LumaENT and Patient Satisfaction Start of enrollment: 2013 Aug 07
Publications & Presentations
PubMed
- 106 citationsParanasal sinus malignancies: an 18-year single institution experience.Larry L. Myers, Brian Nussenbaum, Carol R. Bradford, Theodoros N. Teknos, Ramon M. Esclamado
The Laryngoscope. 2002-11-01 - 186 citationsAssociation of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review.Evan M. Graboyes, Anvesh R. Kompelli, David M. Neskey, Emily Brennan, Shaun A. Nguyen
JAMA Otolaryngology-- Head & Neck Surgery. 2019-02-01 - 96 citationsNeoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L Skidmore
Clinical Cancer Research. 2020-10-01
Journal Articles
- Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell CarcinomaBrian Nussenbaum, Evan M Graboyes, JAMA Otolaryngology–Head & Neck Surgery
- Association of Treatment Delays with Survival for Patients with Head and Neck CancerBrian Nussenbaum, David M Neskey, Evan M Graboyes, Shaun Nguyen, Graham W Warren, JAMA
- Predictors of Acute Throat or Esophageal Patient Reported Pain During Radiation Therapy for Head and Neck CancerHiram A Gay, Bruce H Haughey, Wade L Thorstad, Douglas R Adkins, Pawel T Dyk, Brian Nussenbaum, Mackenzie D Daly, Jason Rich, Clinical and Translational Radiation Oncology
Authored Content
- Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell CarcinomaApril 2020
Press Mentions
A Remarkable Year in Foundation EducationSeptember 2nd, 2024
What I Learned from Navy SEALs About ResilienceFebruary 15th, 2019
ABOto Executive Director Talks Leadership, Physician WellnessJanuary 9th, 2018- Join now to see all
Grant Support
- Biologic Effects Of Bone Morphogenetic Proteins On Oral CancerNational Institute Of Dental &Craniofacial Research2007
- Biologic Effects Of Bone Morphogenetic Proteins On Oral CancerNational Institute Of Dental &Craniofacial Research2006
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
